Shares of Glenmark Pharmaceuticals Ltd jumped more than 4% on 10 December following the company’s announcement that the initial clinical data for its blood cancer...
The shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% higher on 17 May after the company announced receiving final approval from the...
Gland Pharma Ltd. announced on Tuesday that the US health government has approved its generic Edaravone injection for the treatment of amyotrophic lateral sclerosis. According...
Shares of Glenmark Pharmaceuticals Ltd were trading in the green and 1% higher on 29 April after the company announced receiving USFDA final approval for...
Glenmark Pharmaceuticals Limited’s share price rose over 6% on Thursday after the company reported its quarterly earnings for October-December. For the third quarter of FY...
Shares of Glenmark Pharmaceuticals were trading in the green on 27 September after its subsidiary Glenmark Speciality SA signed an agreement with Cosmo Pharmaceuticals NV...
Glenmark Pharmaceuticals shares tumbled 6% on 22 September after the company agreed to divest 75% of its stake in subsidiary Glenmark Life Sciences to Nirma....
Glenmark Pharmaceutical has entered into an agreement with the United States Department of Justice, Antitrust Division (DOJ) to resolve charges alleging its involvement with Teva...
Shares of Glenmark Pharmaceuticals Ltd rose 2.6% on December 21 after the company said it had launched Zita-Piomet for type 2 diabetes. The stock hit...